NHC (NHFPC)

Explore the landscape of NHC (NHFPC) in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on NHC (NHFPC) to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Novo Nordisk Licenses Nanexa's PharmaShell Platform in Up to EUR 1.165 Billion Global Deal – Targeting Monthly and Quarterly Long‑Acting Injectables for Obesity and Type 2 Diabetes
CompanyDeals

Novo Nordisk Licenses Nanexa’s PharmaShell Platform in Up to EUR 1.165 Billion Global Deal – Targeting Monthly and Quarterly Long‑Acting Injectables for Obesity and Type 2 Diabetes

Nanexa AB (STO: NANEXA), a Swedish drug delivery platform company, announced a global exclusive license and collaboration agreement with Novo Nordisk (NYSE: NVO) for the use of the PharmaShell technology…

European Commission Revokes Hansoh's Aumolertinib Marketing Authorization – EU Approval Reversed Seven Months After Grant in TAGRISSO Data‑Protection Dispute

European Commission Revokes Hansoh’s Aumolertinib Marketing Authorization – EU Approval Reversed Seven Months After Grant in TAGRISSO Data‑Protection Dispute

Merck's Subcutaneous Pembrolizumab Approved by China's NMPA Across 19 Solid Tumor Indications – First and Only Subcutaneous PD‑1 Inhibitor in China

Merck’s Subcutaneous Pembrolizumab Approved by China’s NMPA Across 19 Solid Tumor Indications – First and Only Subcutaneous PD‑1 Inhibitor in China

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Policy / Regulatory

China’s COVID-19 Vaccination Second Booster Shot Plan Released

CompanyDrug

Ascletis Pharma Announces Positive Phase I Results for ASC10 in COVID-19 Treatment

Policy / Regulatory

Shanghai Unveils Policies to Boost Global Biomedical R&D Hub

Policy / Regulatory

China Releases 14th Five-Year Plan for National Health Informatization

CompanyDeals

Organon Signs MOU with China’s National Health Commission at CIIE

Policy / Regulatory

China’s National Plan to Combat Microbial Drug Resistance Released

CompanyDeals

J&J MedTech Joins China’s Surgical Training Program to Skill Up Surgeons

Policy / Regulatory

China’s Health Commission Promotes Medical-Elderly Care Integration

Show More